340 related articles for article (PubMed ID: 30500943)
1. Perioperative Management of Buprenorphine: Solving the Conundrum.
Quaye AN; Zhang Y
Pain Med; 2019 Jul; 20(7):1395-1408. PubMed ID: 30500943
[TBL] [Abstract][Full Text] [Related]
2. Continuation of Buprenorphine to Facilitate Postoperative Pain Management for Patients on Buprenorphine Opioid Agonist Therapy.
Mehta D; Thomas V; Johnson J; Scott B; Cortina S; Berger L
Pain Physician; 2020 Mar; 23(2):E163-E174. PubMed ID: 32214293
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.
Roux P; Sullivan MA; Cohen J; Fugon L; Jones JD; Vosburg SK; Cooper ZD; Manubay JM; Mogali S; Comer SD
Pain; 2013 Aug; 154(8):1442-8. PubMed ID: 23707283
[TBL] [Abstract][Full Text] [Related]
4. Perioperative Buprenorphine Continuous Maintenance and Administration Simultaneous With Full Opioid Agonist: Patient Priority at the Interface Between Medical Disciplines.
Acampora GA; Nisavic M; Zhang Y
J Clin Psychiatry; 2020 Jan; 81(1):. PubMed ID: 31917908
[TBL] [Abstract][Full Text] [Related]
5. Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction.
Worley MJ; Heinzerling KG; Shoptaw S; Ling W
Addiction; 2017 Jul; 112(7):1202-1209. PubMed ID: 28164407
[TBL] [Abstract][Full Text] [Related]
6. Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period.
Lembke A; Ottestad E; Schmiesing C
Pain Med; 2019 Mar; 20(3):425-428. PubMed ID: 29452378
[No Abstract] [Full Text] [Related]
7. Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data.
Hjelmström P; Banke Nordbeck E; Tiberg F
Drug Dev Ind Pharm; 2020 Jan; 46(1):1-7. PubMed ID: 31914818
[No Abstract] [Full Text] [Related]
8. A prospective, randomized trial of the effect of buprenorphine continuation versus dose reduction on pain control and post-operative opioid use.
Quaye A; Silvia K; Richard J; Ibrahim Y; Craig WY; Rosen C
Medicine (Baltimore); 2022 Dec; 101(51):e32309. PubMed ID: 36595741
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine Formulations: Clinical Best Practice Strategies Recommendations for Perioperative Management of Patients Undergoing Surgical or Interventional Pain Procedures.
Jonan AB; Kaye AD; Urman RD
Pain Physician; 2018 Jan; 21(1):E1-E12. PubMed ID: 29357325
[TBL] [Abstract][Full Text] [Related]
10. Perioperative Pain and Addiction Interdisciplinary Network (PAIN): protocol of a practice advisory for the perioperative management of buprenorphine using a modified Delphi process.
Goel A; Azargive S; Weissman JS; Shanthanna H; Ladha KS; Lamba W; Duggan S; Hanlon JG; Di Renna T; Peng P; Clarke H
BMJ Open; 2019 May; 9(5):e027374. PubMed ID: 31122990
[TBL] [Abstract][Full Text] [Related]
11. Perioperative Buprenorphine Management: A Multidisciplinary Approach.
Hickey T; Abelleira A; Acampora G; Becker WC; Falker CG; Nazario M; Weimer MB
Med Clin North Am; 2022 Jan; 106(1):169-185. PubMed ID: 34823729
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects.
Wachman EM; Saia K; Miller M; Valle E; Shrestha H; Carter G; Werler M; Jones H
Clin Ther; 2019 Sep; 41(9):1681-1689. PubMed ID: 31358302
[TBL] [Abstract][Full Text] [Related]
13. The problem of pain: Additive analgesic effect of tramadol and buprenorphine in a patient with opioid use disorder.
Montalvo C; Genovese N; Renner J
Subst Abus; 2019; 40(2):136-139. PubMed ID: 30835647
[No Abstract] [Full Text] [Related]
14. Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series.
Martin YN; Deljou A; Weingarten TN; Schroeder DR; Sprung J
BMC Anesthesiol; 2019 May; 19(1):68. PubMed ID: 31068127
[TBL] [Abstract][Full Text] [Related]
15. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.
Korthuis PT; Fiellin DA; Fu R; Lum PJ; Altice FL; Sohler N; Tozzi MJ; Asch SM; Botsko M; Fishl M; Flanigan TP; Boverman J; McCarty D;
J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1(Suppl 1):S83-90. PubMed ID: 21317600
[TBL] [Abstract][Full Text] [Related]
16. Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: A retrospective case series.
Peckham AM; Kehoe LG; Gray JR; Wakeman SE
J Subst Abuse Treat; 2021 Jul; 126():108316. PubMed ID: 34116808
[TBL] [Abstract][Full Text] [Related]
17. Patterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone.
Mannelli P; Douaihy AB; Zavod A; Legedza A; Akerman SC; Sullivan MA
Am J Drug Alcohol Abuse; 2021 Nov; 47(6):753-759. PubMed ID: 34752714
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy.
Perry BN; Vais S; Boateng JO; Jain M; Wachman EM; Saia KA
J Addict Med; 2022 Nov-Dec 01; 16(6):e399-e404. PubMed ID: 35916423
[TBL] [Abstract][Full Text] [Related]
19. Mobile, Community-Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study.
Iheanacho T; Payne K; Tsai J
Am J Addict; 2020 Nov; 29(6):485-491. PubMed ID: 32367557
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine Induction in Persons With Opioid Use Disorder Hospitalized with Acute Hepatitis A.
Oller DA; Thornton C; Nuzzo PA; Fanucchi LC
J Addict Med; 2021 May-Jun 01; 15(3):187-190. PubMed ID: 32909986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
